“We may also be planning to the fact that China could be the quickest-developing area for medical trials.”He has also finished government management in the Indian Institute of Administration Bangalore (IIMB), India. Ravi prospects all aspects of manufacturing processes of biologics/biosimilars, forming a diversified portfolio of products which